Advik Laboratories Ltd.
| BSE: 531686 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE537C01019 |
| BSE 00:00 | 13 Apr | 0.97 |
0 (0.00%) |
OPEN
0.97 |
HIGH
0.97 |
LOW
0.97 |
| NSE 05:30 | 01 Jan | Advik Laboratories Ltd |
| OPEN | 0.97 |
| PREVIOUS CLOSE | 0.97 |
| VOLUME | 250 |
| 52-Week high | 0.97 |
| 52-Week low | 0.37 |
| P/E | |
| Mkt Cap.(Rs cr) | 2 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Advik Laboratories Ltd. (ADVIKLABS) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 953.00 | 38.35 | 4.19 | 13266.48 |
| Cipla | 938.70 | 24.50 | 2.68 | 12659.15 |
| Sun Pharma.Inds. | 646.05 | 13.10 | 2.07 | 12531.93 |
| Dr Reddy's Labs | 4893.00 | 50.55 | 1.04 | 11850.40 |
| Lupin | 1055.85 | 6.10 | 0.58 | 11025.66 |
| Apollo Hospitals | 3060.20 | 69.40 | 2.32 | 9794.50 |
| Glenmark Pharma. | 571.90 | 35.10 | 6.54 | 6712.63 |
| Alkem Lab | 2790.45 | 43.00 | 1.57 | 6677.08 |
| Cadila Health. | 527.00 | 23.00 | 4.56 | 6347.40 |
| Torrent Pharma. | 2619.15 | 52.85 | 2.06 | 6168.44 |
| Divi's Lab. | 3823.70 | 40.75 | 1.08 | 5310.57 |
| Ipca Labs. | 2143.20 | 41.50 | 1.97 | 4337.82 |
| Piramal Enterp. | 1719.50 | 4.45 | 0.26 | 4219.19 |
| Alembic Pharma | 1000.60 | 28.60 | 2.94 | 4132.55 |
| Abbott India | 14962.95 | 21.30 | 0.14 | 4093.14 |
| Glaxosmi. Pharma | 1469.60 | 6.00 | 0.41 | 3224.68 |
| Jubilant Pharmo | 724.10 | -2.15 | -0.30 | 3139.90 |
| Sanofi India | 8050.70 | 11.55 | 0.14 | 2901.10 |
| Laurus Labs | 446.15 | 9.80 | 2.25 | 2797.34 |
| Gland Pharma | 2629.10 | 145.80 | 5.87 | 2633.24 |
Quick Links for Advik Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
